Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetes
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: We evaluated the predictive power of home blood pressure and clinic blood pressure based on the long-term cardiovascular outcome in hypertensive patients with and without impaired glucose metabolism (IGM). METHOD: The multicentre Hypertension Objective Treatment Based on Measurement by Electrical Devices Blood Pressure trial (HOMED-BP) involved 3080 patients (50.5% women; mean age 59.7 years) with a baseline, untreated home/clinic blood pressure as well as follow-up, on-treatment blood pressure. Of those, 979 had IGM and 475 of these patients had diabetes. We applied Cox regression pooling all participants in a cohort analysis in which IGM and normal glucose metabolism (NGM) were separated. RESULTS: During median 5.45 years follow-up, cardiovascular events occurred in 48 patients with IGM and 53 patients with NGM. Baseline home SBP significantly predicted cardiovascular outcome among IGM group [hazard ratio 1.68, 95% CI 1.26-2.26, P = 0.0005]. On-treatment home blood pressure was a significant predictor for cardiovascular risk even after the further adjustment of baseline blood pressure level (P ≤ 0.027), whereas on-treatment clinic blood pressure was not in NGM group (P ≥ 0.37). The event rate in IGM was approximately two times higher than that in NGM (9.95 vs. 4.88 per 1000 patient-years), resulted to the low 5-year number needed to treat in IGM patients [83 vs. 121 for 1-SD (13.1 mmHg) home SBP reduction, and 62 vs. 104 for 1-SD (9.5 mmHg) home DBP reduction). CONCLUSION: The present findings suggest that long-term cardiovascular risk in IGM patients should be assessed based on home blood pressure, not on clinic blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression
Vittinghoff, E., & McCulloch, C. E. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk052 · Cited by 4,359 · cited 1×
“In general, Cox models should be used with at least 10 events per variable, and is acceptable with 5–9 events per variable [46].”
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598 · cited 1×
“BP) trial, patients were randomly assigned to intensive or standard therapy group [33].”
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000150859.47929.8e · Cited by 2,051
Parati, G., Stergiou, G. S., Asmar, R., Bilo, G., de Leeuw, P., Imai, Y., Kario, K., Lurbe, E., Manolis, A., Mengden, T., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328308da66 · Cited by 837 · cited 1×
“Furthermore, home blood pressure offers specific advantages, because it allows for the identification of patients with white-coat, masked and sustained hypertension with readings taken under standardized home conditions, little measurement variability and good reproducibility [3,4].”
Self-citationLong-term follow-up after tight control of blood pressure in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Neil, H. A. W., & Matthews, D. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806359 · Cited by 762 · cited 3×
“com After the interventional trial of UKPDS closed, the survivor of the trial had been monitored 10 years with both groups combined and asked for the lowest feasible blood pressure levels [34,35].”
Global guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care
IDF Clinical Guidelines Task Force (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01918.x · Cited by 433
Niiranen, T. J., Hänninen, M.-R., Johansson, J., Reunanen, A., & Jula, A. M. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149336 · Cited by 390
Ohkubo, T., Asayama, K., Kikuya, M., Metoki, H., Hoshi, H., Hashimoto, J., Totsune, K., Satoh, H., & Imai, Y. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00009 · Cited by 287 · cited 2×
“The predictive value of home pressure increased progressively with the number of measurements [37].”
Self-citation
Cited by
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
“Furthermore, in the HOMED-BP Study conducted in Japan, involving patients with essential hypertension, the home blood pressure during antihypertensive treatment was reported to be closely associated with the risk for onset of or death from cardiovascular diseases than office blood pressure [54, 269].”
BackgroundSelf-citationHome blood pressure monitoring: Australian Expert Consensus Statement
Sharman, J. E., Howes, F. S., Head, G. A., McGrath, B. P., Stowasser, M., Schlaich, M., Glasziou, P., & Nelson, M. R. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000673 · Cited by 83
Satoh, M., Maeda, T., Hoshide, S., & Ohkubo, T. (2019) · Hypertension Research · doi:10.1038/s41440-019-0221-y · Cited by 28
Self-citationShimada, K., Kario, K., Kushiro, T., Teramukai, S., Zenimura, N., Ishikawa, Y., Okuda, Y., & Saito, I. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000966 · Cited by 24
Metadata
- Authors
- Noguchi, Y., Asayama, K., Staessen, J. A., Inaba, M., Ohkubo, T., Hosaka, M., Satoh, M., Kamide, K., Awata, T., Katayama, S., & Imai, Y.
- Venue
- Journal of Hypertension
- Published
- 2013-08
- Volume
- 31
- Issue
- 8
- Pages
- 1593-1602
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1974267190
- Cited by
- 53
- References
- 13
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetes. https://app.cochat.ai/papers/10.1097/hjh.0b013e328361732c
- The paper
- Noguchi, Y., Asayama, K., Staessen, J. A., Inaba, M., Ohkubo, T., Hosaka, M., Satoh, M., Kamide, K., Awata, T., Katayama, S., & Imai, Y. (2013). Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetes. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e328361732c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.